Genetic Factors Influencing Semaglutide Response Not all patients respond identically to semaglutide due to variations in GLP-1 receptor genetics and metabolic pathways
Low Libido/Sexual Dysfunction: A measurable decline in sex drive or difficulty achieving erections
However, despite improvements in OSA-related symptoms and hypertension, PAP has not demonstrated a benefit on composite cardiovascular endpoints in randomized controlled trials for primary [23] or secondary cardiovascular prevention [24,25,26]
The total daily insulin dose requirement was reduced with oral semaglutide compared with placebo, without a clear link between insulin regimen subgroup and the change in total daily insulin dose
However, the results vary from person to person
Substantial weight loss may create a temporary discrepancy between the internal body self and the changed physical appearance, a phenomenon described in qualitative and psychodynamic work as ghost fat or identity lag [70, 71]